The utility of therapeutic plasmapheresis for neurological disorders. NIH Consensus Development.
D000690:Amyotrophic Lateral Sclerosis / Q000628:therapy; D003711:Demyelinating Diseases / Q000628:therapy; D006801:Humans; D009103:Multiple Sclerosis / Q000628:therapy; D009157:Myasthenia Gravis / Q000628:therapy; D009316:National Institutes of Health (U.S.); D009422:Nervous System Diseases / Q000628:therapy*; D009468:Neuromuscular Diseases / Q000628:therapy; D010265:Paraproteinemias / Q000628:therapy; D010956:Plasmapheresis / Q000009:adverse effects / Q000379:methods; D011129:Polyradiculoneuropathy / Q000628:therapy; D014481:United States